These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25139561)

  • 1. Tissue-specific actions of FXR in metabolism and cancer.
    Gadaleta RM; Cariello M; Sabbà C; Moschetta A
    Biochim Biophys Acta; 2015 Jan; 1851(1):30-9. PubMed ID: 25139561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor: A "homeostat" for hepatic nutrient metabolism.
    Massafra V; van Mil SWC
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):45-59. PubMed ID: 28986309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
    Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
    Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
    Prawitt J; Caron S; Staels B
    Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor is essential for normal glucose homeostasis.
    Ma K; Saha PK; Chan L; Moore DD
    J Clin Invest; 2006 Apr; 116(4):1102-9. PubMed ID: 16557297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear bile acid receptor FXR in the hepatic regeneration.
    Chen WD; Wang YD; Meng Z; Zhang L; Huang W
    Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
    Kumari A; Pal Pathak D; Asthana S
    Int J Biol Sci; 2020; 16(13):2308-2322. PubMed ID: 32760200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear bile acid signaling through the farnesoid X receptor.
    Mazuy C; Helleboid A; Staels B; Lefebvre P
    Cell Mol Life Sci; 2015 May; 72(9):1631-50. PubMed ID: 25511198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids and colon cancer: Is FXR the solution of the conundrum?
    Gadaleta RM; Garcia-Irigoyen O; Moschetta A
    Mol Aspects Med; 2017 Aug; 56():66-74. PubMed ID: 28400119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity.
    Cheng Q; Inaba Y; Lu P; Xu M; He J; Zhao Y; Guo GL; Kuruba R; de la Vega R; Evans RW; Li S; Xie W
    Mol Endocrinol; 2015 Apr; 29(4):571-82. PubMed ID: 25719402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
    Maran RR; Thomas A; Roth M; Sheng Z; Esterly N; Pinson D; Gao X; Zhang Y; Ganapathy V; Gonzalez FJ; Guo GL
    J Pharmacol Exp Ther; 2009 Feb; 328(2):469-77. PubMed ID: 18981289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease.
    van Zutphen T; Bertolini A; de Vries HD; Bloks VW; de Boer JF; Jonker JW; Kuipers F
    Handb Exp Pharmacol; 2019; 256():207-234. PubMed ID: 31236687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR).
    Merk D; Gabler M; Gomez RC; Flesch D; Hanke T; Kaiser A; Lamers C; Werz O; Schneider G; Schubert-Zsilavecz M
    Bioorg Med Chem; 2014 Apr; 22(8):2447-60. PubMed ID: 24685112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective.
    Nolan JD; Johnston IM; Walters JR
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):49-56. PubMed ID: 23265149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.